Profusa, Inc.

Profusa, Inc., trading under the ticker PFSA, is a medical-technology company operating in the continuous biosensing and implantable diagnostics sector. The company filed an 8-K with the Securities and Exchange Commission on August 14, 2026, under accession number 0001213900-26-089362, disclosing a material event subject to reporting obligations. Profusa has developed biointegratable sensor technology designed for real-time, continuous monitoring of physiological chemistry, positioning it within the broader digital health and wearable-adjacent medtech landscape. The sponsor name associated with the SPAC vehicle has not been independently confirmed at time of publication. For full filing details, deal timeline, sponsor history, and live SPAC status on PFSA, create a free account at SpacDesk.